Conjugated biological molecules, pharmaceutical compositions and methods
WO2020198699A2
Companion diagnostic assay for globo-h related cancer therapy
TW202045731A
Methods of making high enantioselective secondary alcohols
WO2020072593A1
Combination therapy using anti-ssea-4 antibody in combination with therapeutic oncology agents
WO2020006176A1
Glycosynthase variants for glycoprotein engineering and methods of use
EP3801607A1
Combination therapy by using anti-globo h or anti-ssea-4 antibody with anti-negative immune check points antibody
WO2019217951A1
Method for predicting human immune response
TW201941788A
Novel saponin adjuvant and evaluation method thereof
CA3089002A1
Crm197 protein expression
TW201919644A
Method for treating leukemia
US2018339061A1
Antibodies, pharmaceutical compositions and methods
KR20190077103A
Conjugated biological molecules, pharmaceutical compositions and methods
TW201817743A
Human antibodies, pharmaceutical compositions and methods
EP3490592A1
Immunogenic/therapeutic glycan compositions and uses thereof
US2017304419A1
Cancer immunotherapy by immune activation or immune modulation via globo series antigens
KR20180121786A
Antibodies, pharmaceutical compositions and methods
EP3390415A1
(r)- and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation
CN108472362A
Novel carbohydrate antibody, medical component and application thereof
